The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAJ Bell Regulatory News (AJB)

Share Price Information for AJ Bell (AJB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 336.00
Bid: 337.00
Ask: 337.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.148%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 336.00
AJB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: AJ Bell (AJB): Platform for growth

24 Jan 2019 07:15

Hardman & Co Research Hardman & Co Research: AJ Bell (AJB): Platform for growth 24-Jan-2019 / 07:15 GMT/BST


Hardman & Co Research: Platform for growth

AJ Bell is one of the largest and fastest-growing investment platforms in the UK. It serves both the adviser market and the DIY investor. Having transitioned to updated technology in 2014, it is well placed to ride the growth in the market and pick up disaffected clients from competitor platforms that are only now upgrading. We anticipate strong profit growth on the back of higher revenues and positive operational gearing. The new asset management business should add further momentum, and higher UK savings rates could be the icing on the cake.

Please click here for the full report:

https://www.hardmanandco.com/research/corporate-research/platform-for-growth-2/

To contact us: Hardman & Co 35 New Broad Street London EC2M 1NH www.hardmanandco.comFollow us on Twitter @HardmanandCo Contact: Jason Streets +44 20 7194 7622 js@hardmanandco.com

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 21 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

769003 24-Jan-2019 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
1st Sep 20229:00 amRNSIssue of Ordinary Shares & Total Voting Rights
1st Sep 20229:00 amRNSDirector/PDMR Shareholding
22nd Aug 20225:04 pmRNSNomination Committee changes
15th Aug 20229:01 amRNSDirector/PDMR Shareholding
12th Aug 20228:52 amRNSDirector/PDMR Shareholding
21st Jul 20227:00 amRNSQ3 Trading Update
12th Jul 20221:04 pmRNSDirector/PDMR Shareholding
30th Jun 20228:12 amRNSIssue of Ordinary Shares & Total Voting Rights
24th Jun 20227:00 amRNSBlock listing six monthly return
16th Jun 20224:42 pmRNSDirectorate Change
15th Jun 20222:22 pmRNSDirector/PDMR Shareholding
1st Jun 20229:41 amRNSDirector/PDMR Shareholding
1st Jun 20229:37 amRNSDirector/PDMR Shareholding
31st May 20224:45 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSInterim Results
13th May 20221:24 pmRNSDirector/PDMR Shareholding
26th Apr 20228:52 amRNSDirector/PDMR Shareholding
21st Apr 20227:00 amRNSQ2 Trading Update
20th Apr 20229:08 amRNSDirector/PDMR Shareholding
13th Apr 20227:00 amRNSDirector/PDMR Shareholding
21st Mar 202210:47 amRNSAdmission of Shares & Total Voting Rights
15th Mar 20222:35 pmRNSDirector/PDMR Shareholding
14th Mar 20222:36 pmRNSDirector/PDMR Shareholding
1st Mar 20224:37 pmRNSIssue of Ordinary Shares & Total Voting Rights
16th Feb 20228:58 amRNSDirector/PDMR Shareholding
14th Feb 202210:43 amRNSHolding(s) in Company
14th Feb 202210:22 amRNSDirector/PDMR Shareholding
4th Feb 20224:09 pmRNSDirector/PDMR Shareholding
27th Jan 202211:54 amRNSDirector/PDMR Shareholding
26th Jan 20224:16 pmRNSResult of AGM
21st Jan 20222:14 pmRNSDirector/PDMR Shareholding
20th Jan 20227:00 amRNSQ1 Trading Update
18th Jan 20222:29 pmRNSDirector/PDMR Shareholding
12th Jan 202211:58 amRNSDirector/PDMR Shareholding
7th Jan 202210:04 amRNSDirector/PDMR Shareholding
7th Jan 202210:02 amRNSDirector/PDMR Shareholding
31st Dec 20217:00 amRNSIssue of Ordinary Shares & Total Voting Rights
24th Dec 20217:00 amRNSBlock Listing Six Monthly Return
17th Dec 20213:47 pmRNSAnnual Report and Notice of AGM
17th Dec 20212:59 pmRNSBoard Changes
14th Dec 20212:50 pmRNSDirector/PDMR Shareholding
13th Dec 20218:35 amRNSDirector/PDMR Shareholding
13th Dec 20218:33 amRNSIssue of Ordinary Shares & Total Voting Rights
8th Dec 20214:51 pmRNSHolding(s) in Company
7th Dec 20213:39 pmRNSDirector/PDMR Shareholding
6th Dec 20215:12 pmRNSDirector/PDMR Shareholding - Replacement
3rd Dec 20214:34 pmRNSDirector/PDMR Shareholding
3rd Dec 202111:13 amRNSDirector/PDMR Shareholding
2nd Dec 20217:01 amRNSAppointment of Chief Financial Officer
2nd Dec 20217:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.